Molecular genetics, pharmacogenetics, and cytogenetics studies
This tender has been awarded
Awarded to Aktsiaselts Ida-Tallinna Keskhaigla; SYNLAB Eesti OÜ; sihtasutus Tartu Ülikooli Kliinikum; Asper Biogene OÜ; sihtasutus Põhja-Eesti Regionaalhaigla — €4,246,000
About This Opportunity
TranslatedConducting molecular genetics, pharmacogenetics, and cytogenetics studies. See tender documents for exclusion grounds and qualification criteria.
This is a services contract in the health and medical services sector. Located in Estonia, Europe, this opportunity is open to firms and consortiums.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: etMolekulaargeneetika, farmakogeneetika ja tsütogeneetika uuringud / Kõrvaldamise alused ja kvalifitseerimistingimused: Vaata hanke alusdokumentidest
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on April 10, 2026. Last refreshed 32 days ago. Original language: et. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Aktsiaselts Lääne-Tallinna Keskhaigla
Aktsiaselts Lääne-Tallinna Keskhaigla has issued 68 procurement notices on BidsFactory, including 1 currently open and 52 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Urban Development & Housing. All notices are published for Estonia. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: June 16, 2026.
Frequently asked questions about this tender
Who is the contracting authority?
This notice was issued by Aktsiaselts Lääne-Tallinna Keskhaigla in Estonia. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Services contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
Aktsiaselts Ida-Tallinna Keskhaigla; SYNLAB Eesti OÜ; sihtasutus Tartu Ülikooli Kliinikum; Asper Biogene OÜ; sihtasutus Põhja-Eesti Regionaalhaigla was awarded the contract for €4,246,000. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Estonia. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Aktsiaselts Ida-Tallinna Keskhaigla; SYNLAB Eesti OÜ; sihtasutus Tartu Ülikooli Kliinikum; Asper Biogene OÜ; sihtasutus Põhja-Eesti Regionaalhaigla. The award notice is archived on BidsFactory for transparency and market intelligence.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.
Sectors & Categories
Contracting Authority
Contact
Companies That Won Similar
Companies with awards in Health & Medical in Estonia